Gregory Fraser
Stock Analyst at Truist Securities
(2)
# 1225
Out of 5,240 analysts
38
Total ratings
55.00%
Success rate
28.47%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ANI Pharmaceuticals | Maintains: Hold | 60 62 | 54.22 | 14.35% | 8 | Oct 22, 2024 | |
Bausch Health Compan... | Maintains: Hold | 8 7 | 7.47 | -6.29% | 2 | Jul 25, 2024 | |
Beyond Air | Maintains: Buy | 10 8 | 0.36 | 2122.22% | 6 | Apr 30, 2024 | |
Biote | Maintains: Buy | 10 9 | 5.67 | 58.73% | 2 | Jan 18, 2024 | |
Amneal Pharmaceutica... | Maintains: Strong Buy | 6 7 | 7.86 | -10.94% | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 26 29 | 51.62 | -43.82% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 95 | 26.29 | 261.35% | 3 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 14 18 | 9.45 | 90.48% | 2 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 45 40 | 13.27 | 201.43% | 2 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 3 | n/a | n/a | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 7 6 | n/a | n/a | 1 | Apr 14, 2022 |